European Society of Cardiology
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 

CVD Prevention in clinical practice (European Guidelines on)

ESC Clinical Practice Guidelines

Topics: Cardiovascular Disease Prevention - Risk Assessment and Management

Summary

The 2012 European Guidelines on CVD Prevention in Clinical Practice is a new shorter and more practical format around the 5 key questions of prevention: what is it, why is it needed, for whom and by whom and how can be provided?
03/05/2012 00:00:00

Current versions available to download

Publication dateVersionsReferencesSize
2012Full TextEuropean Guidelines on CVD Prevention in Clinical Practice5 MB
 Pocket guidelines
 Pocket guidelinesCompendium of Abridged ESC Guidelines
 PdaPDA
 CME Questionshours of External CME credits

Authors

Joep Perk (Chairperson) (Sweden), Guy De Backer (Belgium), Helmut Gohlke (Germany), Ian Graham (Ireland), Zeljko Reiner (Croatia), Monique Verschuren (The Netherlands), Christian Albus (Germany),Pascale Benlian (France), Gudrun Boysen (Denmark), Renata Cifkova5 (Czech Republic), Christi Deaton (UK), Shah Ebrahim (UK), Miles Fisher (UK),Giuseppe Germano (Italy), Richard Hobbs(UK), Arno Hoes (The Netherlands),Sehnaz Karadeniz (Turkey), Alessandro Mezzani (Italy), Eva Prescott (Denmark),Lars Ryden (Sweden), Martin Scherer7 (Germany), Mikko Syvanne (Finland),Wilma J.M. Scholte Op Reimer (The Netherlands), Christiaan Vrints (Belgium),David Wood (UK), Jose Luis Zamorano (Spain), Faiez Zannad (France).

Table of contents: Full Text (ESC Clinical Practice Guidelines)

What is cardiovascular disease prevention?

  • Introduction, development of the Guidelines, evaluation methods, combining evaluation methods 

What is prevention of cardiovascular disease needed?

  • Scope of the problem, prevention of cardiovascular disease: a lifelong approach, prevention of cardiovascular desease pays off, ample room for improvement

Who should benefit from it?

  • Strategies and risk estimation, genetics, age and gender, psychological risk factors, other biomarkers of risk, imaging methods in CVD prevention, other diseases with increase risk for CVD 

How can CVD prevention be used?

  • Principles of behavior change, smoking, nutrition, physical activity, management of psychological factors, body weight, blood pressure, treatment targets in patients with type 2 diabetes, lipids, antithrombotics, adherence 

Where should programmes be offered?

  • CVD in primary care: role of nurses, CVD in general practice, CVD in primary care: role of cardiologists, primary care-based self-help programmes, hopital-based programmes: hopital services, hospital-based programmes: specialized prevention  centres, non-governemental organization programmes, action at the European level  

Previous versions

2007 EHJ 2007 (28):2375-2414 Executive Summary
2007 EJCPR 2007; vol 14 (suppl 2:S1-S113 Full Text
2003  EHJ 2003;24:1601-1610  Executive Summary
2003 EJPCR, 2003, 10 (Suppl 1): S1-S78)  Full Text
2001 Prevention of coronary heart disease in clinical practice

 Slides

1998 Prevention of coronary heart disease in clinical practice Report